Revealed: The very unflattering side-effect of Ozempic... and the experts' guide to fixing it The Ozempic weight-loss drug has helped many reach their target size and shape already, with little sense of privation at all. But there's a problem. With rapid weight loss comes sag, and lots of it.... https://lnkd.in/eUf2gVaT #BioTech #science
Biotech feed’s Post
More Relevant Posts
-
𝗜𝗱𝗲𝗮𝘆𝗮 𝘀𝗵𝗼𝘄𝗰𝗮𝘀𝗲𝘀 𝗽𝗿𝗼𝗼𝗳-𝗼𝗳-𝗰𝗼𝗻𝗰𝗲𝗽𝘁 𝗱𝗮𝘁𝗮 𝗶𝗻 𝗮 𝗯𝗼𝗼𝘀𝘁 𝘁𝗼 𝘀𝘆𝗻𝘁𝗵𝗲𝘁𝗶𝗰 𝗹𝗲𝘁𝗵𝗮𝗹𝗶𝘁𝘆 𝗽𝗹𝗮𝘆 Fresh Phase 2 data are adding weight to Ideaya IDEAYA Biosciences case for a targeted therapy it believes could be a first-in-class treatment option for certain …Yujiro S. H. https://lnkd.in/d-wViywi
Ideaya Biosciences reports Phase 2 data for MAT2A inhibitor IDE397
https://endpts.com
To view or add a comment, sign in
-
See Aquasite in action on hermite.dp.tech Water molecules are crucial in mediating interactions between drugs and their target proteins. In drug design, strategically replacing water molecules and engaging them in interactions is a key strategy for optimizing compound structures. Aquasite calculates the free energy of individual water molecules to pinpoint stable and unstable water molecules at target binding sites, offering essential insights and guidance for drug design.
To view or add a comment, sign in
-
Professor of Phytochemistry at Shiraz University of Medical Sciences and Mentor of Aryana Phytochemistry of Tirazis Co.
We have published another Review Paper in Phytochemical Analysis titled: "Chemometric-based drug discovery approaches from natural origins using hyphenated chromatographic techniques". using following link you may study it. https://lnkd.in/dFwNFhNY
To view or add a comment, sign in
-
What is the best way to assess your lab’s vulnerability to disaster? The National Institutes of Health suggests “occurrence mapping.” To make the best use of time and resources, users should first pay attention to “events that would have higher impact and higher likelihood, and less attention on issues that are unlikely to occur or would have little impact.” To prepare your lab against disaster, check the link below! #pharma #lifescience #environmentalmonitoring #biotech https://hubs.ly/Q02vB68m0
Emergency Planning
To view or add a comment, sign in
-
Start Free Trial 👇 https://lnkd.in/gnAcAJq5 The online system of Bio-product Molecule Assessment and Optimization Platform Platform (#AlfaDAX) was launched. The AlfaDAX system enables customers to quickly screen and modify protein candidates before they enter the CMC stage, reducing trail ad error costs and accelerating the development of new drugs. See the following user guide video. #GreatBayBio #GBB #AlfaDAX #molecule #druggability #assessment #optimization
To view or add a comment, sign in
-
Resolian Video Series: Chapter 5 Day five of our video series featuring our CEO Patrick Bennett with Chris Conner from Life Science Marketing Radio. 🔍 "Logistics Mastery for Seamless Global Operations" Handling samples across borders involves intricate considerations, from stability to hazards. Resolian's expertise shines in navigating these complexities, particularly evident in China where HGRAC regulations pose challenges to the movement of human-based samples. 🎬 Watch the video here to find out more about Resolian’s logistics capabilities. #Resolian #VideoSeries #CompanyCulture #LabInnovation #WatchNow #Bioanalytics #bioanalyticalservices #AnalyticalSciences #ContractResearchOrganization #CRO #biotech #lifescience #pharma #drugdevelopment 🎥
To view or add a comment, sign in
-
PRESS RELEASE 👉 Touchlight’s enzymatic doggybone DNA used in the manufacture of Versameb AG’s VMB-100 for first-in-human clinical study. Touchlight's proprietary doggybone DNA (dbDNA) has been used as a critical starting material for manufacturing of VMB-100, a potency enhanced messenger ribonucleic acid (mRNA) encoding human insulin-like growth factor-1 (IGF-1) to support Versameb’s first-in-human clinical study to treat chronic stress urinary incontinence (SUI). Read the full press release here - https://lnkd.in/e-J3ra95 Learn more about Touchlight's regulatory experience and achievements - https://lnkd.in/eUkGwAwX #biotech #biotechnews #genetherapy #celltherapy #lifesciences #drugdevelopment #regulatory
To view or add a comment, sign in
-
In the latest Bio Banter episode, Michael Margolis, RPh., and Daniel Parisotto, Ph.D., discuss the fascinating world of private biotech markets. Do they see continued strength or decline? On the one hand, deal-making activities declined from the zeal of the pandemic highs, but things still look good compared to pre-pandemic metrics… Curious for more? Tune in today. https://bit.ly/41SkaAH #Therapeutics #Biotech #LetsTalkFuture #ThePowerofOppenheimerThinking
To view or add a comment, sign in
-
International Director Sales and Marketing | Science | Chromatography Specialist | B2B | Ice speed skater
ASMS, Anaheim, California... we are there and present super cool data: > MP 172 Disinfection By-products from Water Chlorination Reconfirmed by Electrochemistry-MS > TP 447 Rapid Assessment of Metabolism by Electrochemistry/MS – Drugs, Xenobiotics, Plants > ThP 380 Comprehensive LC-PAD/MS Analysis of N-glycans using SweetSep™ HPAEC column
To view or add a comment, sign in
199 followers